- Home
- BMRN vs THM Comparison
BMRN vs THM Comparison
Compare BMRN & THM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- THM
- Stock Information
- Founded
- BMRN 1996
- THM 1978
- Country
- BMRN United States
- THM Canada
- Employees
- BMRN N/A
- THM N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- THM
- Sector
- BMRN Health Care
- THM
- Exchange
- BMRN Nasdaq
- THM Nasdaq
- Market Cap
- BMRN 13.7B
- THM N/A
- IPO Year
- BMRN 1999
- THM N/A
- Fundamental
- Price
- BMRN $70.52
- THM $0.65
- Analyst Decision
- BMRN Buy
- THM
- Analyst Count
- BMRN 22
- THM 0
- Target Price
- BMRN $94.00
- THM N/A
- AVG Volume (30 Days)
- BMRN 1.6M
- THM 265.4K
- Earning Date
- BMRN 04-23-2025
- THM 05-09-2025
- Dividend Yield
- BMRN N/A
- THM N/A
- EPS Growth
- BMRN 153.71
- THM N/A
- EPS
- BMRN 2.21
- THM N/A
- Revenue
- BMRN $2,853,915,000.00
- THM N/A
- Revenue This Year
- BMRN $12.23
- THM N/A
- Revenue Next Year
- BMRN $9.90
- THM N/A
- P/E Ratio
- BMRN $31.97
- THM N/A
- Revenue Growth
- BMRN 17.97
- THM N/A
- 52 Week Low
- BMRN $60.63
- THM $0.40
- 52 Week High
- BMRN $94.85
- THM $0.80
- Technical
- Relative Strength Index (RSI)
- BMRN 59.12
- THM 74.09
- Support Level
- BMRN $69.89
- THM $0.46
- Resistance Level
- BMRN $73.51
- THM $0.66
- Average True Range (ATR)
- BMRN 2.04
- THM 0.04
- MACD
- BMRN 0.16
- THM 0.02
- Stochastic Oscillator
- BMRN 52.81
- THM 87.45
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.